Ornithine transcarbamylase deficiency in adolescence and adulthood

被引:0
|
作者
Buerle, M. [1 ]
Mende, H. [1 ]
Plum, U. [1 ]
Bluthardt, M. [2 ]
Walka, M. [3 ]
Geldner, G. [1 ]
机构
[1] Klinikum Ludwigsburg, Klin Anasthesiol Intens Med Schmerzther & Notfall, D-71640 Ludwigsburg, Germany
[2] Klinikum Ludwigsburg, Neurol Klin, D-71640 Ludwigsburg, Germany
[3] Klinikum Ludwigsburg, Klin Kinder & Jugendmed, D-71640 Ludwigsburg, Germany
来源
ANAESTHESIST | 2009年 / 58卷 / 06期
关键词
Ornithine transcarbamylase (OTC) deficiency; Urea cycle defect; Cerebral herniation; HYPERAMMONEMIA; DIAGNOSIS;
D O I
10.1007/s00101-009-1540-1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Ornithine transcarbamylase (OTC) deficiency is the most frequent innate disorder of the urea cycle and is X-chromosome linked. The disease normally manifests itself shortly after birth and is fatal when untreated. Due to the different expression and X-chromosomal inheritance the manifestation of symptoms can appear later particularly in girls and young women. The first symptoms are non-specific signs of elevated cerebral pressure as a result of a hyperammonemia, which range from nausea and headache up to cerebral herniation with fatal outcome. Measurement of plasma ammonia levels is a simple yet important screening test for patients with unexpected stupor or delirium. The two case reports show the clinical range from acute decompensation with acute cerebral herniation followed by fatal outcome to recovery under emergency therapy without substantial neurological deficits. Emergency treatment consists of symptomatic securing of vital parameters and an immediate reduction in the ammonia level using high calorie, protein-free nutrition to avoid catabolism together with administration of arginine, benzoate or phenyl butyrate. In cases of coma with severe cerebral edema and the threat of a herniation reaction or excessive ammonia levels, emergency hemodialysis must be immediately carried out. In the clinical routine it is extremely important to consider a metabolic defect at an early phase and among others to determine the ammonia level so that the appropriate treatment can be instigated in time.
引用
收藏
页码:594 / 601
页数:8
相关论文
共 50 条
  • [41] Recurrent pancreatitis in ornithine transcarbamylase deficiency
    Prada, Carlos E.
    Kaul, Ajay
    Hopkin, Robert J.
    Page, Kimberley I.
    Nathan, Jaimie D.
    Bartholomew, Dennis W.
    Cohen, Mitchell B.
    Heubi, James E.
    Leslie, Nancy D.
    Burrow, T. Andrew
    MOLECULAR GENETICS AND METABOLISM, 2012, 106 (04) : 482 - 484
  • [42] mRNA THERAPY FOR ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    Sablad, Marciano
    Bao, Yanjie
    Vega, Jerel
    Bhaskaran, Hari
    Perez-Garcia, Carlos
    Gonzalez, Jose
    Dam, Thanhchau
    Limphong, Patty
    Davis, Jared
    Karmali, Priya
    Parker, Suezanne
    Chivukula, Pad
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 324 - 324
  • [43] ESTABLISHING HETEROZYGOSITY FOR ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    POTTER, M
    HAMMOND, J
    WILCKEN, B
    AUSTRALIAN PAEDIATRIC JOURNAL, 1987, 23 (01): : 67 - 68
  • [44] Brain images in ornithine transcarbamylase deficiency
    Miura, Ken
    Ikeda, Ken
    Kawabe, Kiyokazu
    Sawada, Masahiro
    Hanashiro, Sayori
    Ito, Hirono
    Iwasaki, Yasuo
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2016, 4 (01): : 36 - 36
  • [45] NEUROPATHOLOGICAL FINDINGS IN ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    HARDING, BN
    LEONARD, JV
    ERDOHAZI, M
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1982, 8 (03) : 240 - 240
  • [46] PRENATAL TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    Wilnai, Yael
    Alcorn, Deborah
    Benitz, William
    Berquist, Wiliam
    Bernstein, Jonathan
    Blumenfeld, Yair J.
    Castillo, Ricardo
    Concepcion, Waldo
    Cowan, Tina
    Cox, Kenneth L.
    Cusmano, Kristina
    Deirdre, Lyell
    Esquival, Carlos
    Hintz, Susan R.
    Homeyer, Margaret
    Hudgins, Louanne
    Palma, Jonathan
    Summar, Marshall L.
    Schelley, Susan
    Vishnu, Priya Adula
    Enns, Gregory M.
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (03) : 248 - 248
  • [47] CARRIER DETECTION IN ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    HOKANSON, JT
    OBRIEN, WE
    IDEMOTO, J
    SCHAFER, IA
    JOURNAL OF PEDIATRICS, 1978, 93 (01): : 75 - 78
  • [48] CARRIER DETECTION IN ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    HOKANSON, JT
    OBRIEN, WE
    SCHAFER, IA
    PEDIATRIC RESEARCH, 1976, 10 (04) : 365 - 365
  • [49] Prenatal treatment of ornithine transcarbamylase deficiency
    Wilnai, Yael
    Blumenfeld, Yair J.
    Cusmano, Kristina
    Hintz, Susan R.
    Alcorn, Deborah
    Benitz, William E.
    Berquist, William E.
    Bernstein, Jonathan A.
    Castillo, Ricardo O.
    Concepcion, Waldo
    Cowan, Tina M.
    Cox, Kenneth L.
    Lyell, Deirdre J.
    Esquivel, Carlos O.
    Homeyer, Margaret
    Hudgins, Louanne
    Hurwitz, Melissa
    Palma, Jonathan P.
    Schelley, Susan
    Akula, Vishnu Priya
    Summar, Marshall L.
    Enns, Gregory M.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (03) : 297 - 300
  • [50] A novel mutation in ornithine transcarbamylase gene identified from a Chinese child with ornithine transcarbamylase deficiency
    Wu, Bo
    Wang, Yi-Zheng
    Cao, Li-Rong
    Zhang, Rui-Ping
    Fang, Yu-Lian
    Zhang, Yu-Qin
    Cai, Chun-Quan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 6344 - 6350